Frontlight ResearchEarly access
Taking peopleNo phase
VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle
Key facts
- Who runs it
- Charite University, Berlin, Germany
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 24 people, planned
- Started
- 10 Sept 2025
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- TRE: Time-restricted eating
- Record updated
- 18 September 2025
Who can take part
- Age
- 60 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 35 criteriaShow less
Who can take part
- Male and female participants, enrolled in a 1:1 ratio
- Age 60-85 years
- Body mass index (BMI) 20-35 kg/m²
- Capacity to give informed consent
- Existing health insurance to allow evaluation and treatment of any incidental findings
- Usual daily eating window > 11 hours
- First meal of the day before 10:00 AM
- Willingness to receive seasonal influenza and COVID-19 vaccination and proof of scheduled appointment
- Willingness and ability to follow a prescribed TRE dietary regimen (8-hour daily eating window; 16-hour fast without any caloric intake)
- Appointment for simultaneous influenza and COVID-19 vaccination pre-arranged with primary care physician and coordinated with study team to align with TRE intervention
Who cannot take part
- Any vaccination (especially influenza and/or COVID-19) within 6 months before the intervention start
- History of influenza infection within 6 months prior to initiation of the study intervention
- History of severe adverse reactions to prior vaccinations
- Immunosuppression (including use of immunosuppressive drugs)
- Participation in any fasting intervention (e.g., TRE, alternate-day fasting, 5:2, 18:6) within 6 months before enrollment
- Antibiotic therapy within 3 months before enrollment
- Weight change > 2 kg in the month before enrollment
- Known substance, drug, or alcohol abuse
- Diabetes mellitus under ongoing pharmacological treatment
- Symptoms of systemic inflammatory or autoimmune disease
- Severe hypertension (systolic > 180 mmHg or diastolic > 110 mmHg)
- Diseases or functional disorders which, in the opinion of the study physician, preclude participation in the study
- Severe, active, or unstable medical conditions requiring treatment
- Acute or chronic infections
- Vaccinations not related to the study, administered during the study period from V0 to V4
- Use of pharmacological weight-loss agents (e.g., semaglutide)
- Participation in another diet or weight-loss program (e.g., intensive athletic training)
- Night-shift or rotating-shift work
- Postoperative recovery phase
- Therapeutic or medically prescribed special diets
- Vegan diet
- Current smoker
- Anemia
- Claustrophobia
- Legal incapacity or any other circumstance that prevents full understanding of the nature, importance, and implications of the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 60 and 85 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to investigate the effects of a four-week time-restricted eating (TRE) intervention on autophagy, immune function, and vaccine response to a seasonal influenza and COVID-19 vaccines in older healthy subjects.
The 2 groups in the trial
- Control (no intervention)No study treatment, for comparison
Four weeks of ad libitum eating pattern with eating time window \>11 h/day. No change of the regular eating pattern.
- TRETreatment being tested
Four weeks of TRE, where the daily eating pattern is reduced to 8 h/day. The first meal will be before 10:00 AM.
Treatment: TRE: Time-restricted eating
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Fit questions
- Built from NCT07000708, who can take part
- Record updated
- 18 September 2025